Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Method and Cerebral Outcomes
NCT03696719Unknown
- Sponsor
- Rabin Medical Center
- Start
- Nov 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine + fentanyl + propofol + rocuronium in benign prostatic hyperplasia (BPH), bladder cancer, urinary incontinence (UI) and 1 more (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Neuron Specific Enolase serum level. Status: unknown.
02
Drugs
lidocaine + fentanyl + propofol + rocuronium
03
Conditions
benign prostatic hyperplasia (BPH)bladder cancerurinary incontinence (UI)pelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT03696719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696719.